T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

JAMA Oncol. 2024 Jun 1;10(6):826-828. doi: 10.1001/jamaoncol.2024.0662.
No abstract available

Plain language summary

This cohort study assesses the increase in second primary malignant neoplasms and T-cell malignant neoplasm cases associated with chimeric antigen receptor–T cells.

MeSH terms

  • Female
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Immunotherapy, Adoptive* / methods
  • Male
  • Receptors, Chimeric Antigen* / immunology
  • T-Lymphocytes / immunology

Substances

  • Receptors, Chimeric Antigen